Corvus Pharmaceuticals Inc. (CRVS)
CRVS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$9.41
-6.37% on the day
Market cap
$791.6M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CRVS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001626971 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-03-13 |
| Latest annual report | 10-K | 2026-03-12 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report FORM 8-K | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 581 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.0% |
| 1 month | -28.5% |
| 3 months | -35.1% |
| Year to date | +20.3% |
| 1 year | +30.3% |
| From 52-week high | -63.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AVBP | ArriVent BioPharma Inc. | $16.09 | -2.25% | $793.4M |
| ARDX | Ardelyx Inc. | $3.12 | -3.41% | $777.5M |
| GERN | Geron Corporation | $1.20 | -1.64% | $771.0M |
| HELP | Helus Pharma Inc. | $10.50 | -4.80% | $767.1M |
| ANL | Adlai Nortye Group Ltd. | $11.76 | -17.34% | $757.0M |
| GYRE | Gyre Therapeutics Inc. | $6.71 | -2.26% | $748.2M |
| APMD | Apnimed Inc. | $17.83 | -4.29% | $742.3M |
| OBX | Obsidian Therapeutics Inc. | $11.99 | -6.25% | $740.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier